Matches in Wikidata for { <http://www.wikidata.org/entity/Q65473803> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65473803 description "clinical trial" @default.
- Q65473803 description "ensayu clínicu" @default.
- Q65473803 description "klinisch onderzoek" @default.
- Q65473803 description "клінічне випробування" @default.
- Q65473803 name "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"" @default.
- Q65473803 name "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Tr" @default.
- Q65473803 type Item @default.
- Q65473803 label "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"" @default.
- Q65473803 label "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Tr" @default.
- Q65473803 prefLabel "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"" @default.
- Q65473803 prefLabel "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Tr" @default.
- Q65473803 P1050 Q65473803-6E62E5B7-BE2C-436B-8FB8-B0D28A26E53D @default.
- Q65473803 P1050 Q65473803-85EE3B0D-CF87-4BDB-ACD6-849E341A2B70 @default.
- Q65473803 P1132 Q65473803-DBDE35B3-CCEC-4199-A878-2F8FB16164B1 @default.
- Q65473803 P1476 Q65473803-7D0CC849-88B9-411D-8D21-1ED75BF6E680 @default.
- Q65473803 P1813 Q65473803-4A5A5FDE-780A-436D-8596-979D3D5D8E93 @default.
- Q65473803 P2899 Q65473803-52E39927-AABC-4A48-8D19-79549669EE81 @default.
- Q65473803 P3098 Q65473803-75BD50AE-1C1B-424B-AD43-4D62AAE80E1E @default.
- Q65473803 P31 Q65473803-2EF4E492-6255-4E1E-9954-B92A56AA15DF @default.
- Q65473803 P580 Q65473803-C62A201F-CA69-49D1-A086-E3D4178787B0 @default.
- Q65473803 P582 Q65473803-3B83E2B4-65F1-45EB-B755-BB01EBB363AB @default.
- Q65473803 P6099 Q65473803-A8019ACD-627D-43B3-A322-6B80BFA05578 @default.
- Q65473803 P8363 Q65473803-64D0DF5A-F755-41AB-81FE-99B4081277DD @default.
- Q65473803 P1050 Q12206 @default.
- Q65473803 P1050 Q202758 @default.
- Q65473803 P1132 "+2346" @default.
- Q65473803 P1476 "A Phase IIIb/IV, Multinational, Multicentre, Randomised, Open Study to Establish the Optimal Method for Initiating and Maintaining Lantus® (Insulin Glargine) Therapy Based on a Comparison of Two Treatment Algorithms to Determine Optimal Metabolic Outcomes, Safety, and Satisfaction in Subjects With Type 1 Diabetes Mellitus/ "HALT" Sub-study: Multicentre, Open Clinical Trial to Assess the Effect of Insulin Glargine on Symptomatic Hypoglycaemia, Fear of Hypoglycaemia and Quality of Life in Patients With Type 1 Diabetes" @default.
- Q65473803 P1813 "AT-LANTUS" @default.
- Q65473803 P2899 "+18" @default.
- Q65473803 P3098 "NCT00390728" @default.
- Q65473803 P31 Q30612 @default.
- Q65473803 P580 "2002-04-01T00:00:00Z" @default.
- Q65473803 P582 "2003-08-01T00:00:00Z" @default.
- Q65473803 P6099 Q42825046 @default.
- Q65473803 P8363 Q78089383 @default.